[1]
Li-Nan Wang, Xiang-Lei Peng, Min Xu, Yuan-Bo Zheng, Yue-Ying Jiao, Jie-Mei Yu, Yuan-Hui Fu, Yan-Peng Zheng, Wu-Yang Zhu, Zhong-Jun Dong, Jin-Sheng He, 2021: Evaluation of the Safety and Immune Efficacy of Recombinant Human Respiratory Syncytial Virus Strain Long Live Attenuated Vaccine Candidates, Virologica Sinica, 36, 706-720. doi: 10.1007/s12250-021-00345-3
[2]
Jianhui Nie, Juan Zhao, Qingqing Chen, Weijin Huang, Youchun Wang, 2014: Three amino acid residues in the envelope of human immunodeficiency virus type 1 CRF07_BC regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody IgG1b12, Virologica Sinica, 29, 299-307. doi: 10.1007/s12250-014-3485-z
[3]
Ningning Ge, Jin Sun, Zhihua Liu, Jiayi Shu, Huimin Yan, Zhihua Kou, Yu Wei, Xia Jin, 2022: An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses, Virologica Sinica, 37, 266-276. doi: 10.1016/j.virs.2022.01.032
[4]
李红霞, 孟小林*, 徐进平, 王健, 鲁伟, 曹旭, 2004: Expression of Recombinant Envelope Proteins VP19 and VP28 of WSSV and Preparation of Neutralizing Antibody, Virologica Sinica, 19, 587-590.
[5]
孙瑜, 刘朝奇, 鲁德银, 曾毅, 1992: Effect of Human Semen and Anaerobic Bacteria Culture Fluid on Induction of Cervical Carcinoma in mice, Virologica Sinica, 7, 11-.
[6]
Xue-ling WU, Chun-tao ZHANG, Xiao-ke ZHU, You-chun WANG, 2010: Detection of HPV Types and Neutralizing Antibodies in Women with Genital Warts in Tianjin City, China, Virologica Sinica, 25, 8-17. doi: 10.1007/s12250-010-3078-4
[7]
Chunpeng Yang, Rui Gong, Natalia de Val, 2019: Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure, Virologica Sinica, 34, 168-174. doi: 10.1007/s12250-019-00093-5
[8]
Dezhi Li, Jie Liu, Li Zhang, Tianshu Xu, Junheng Chen, Liping Wang, Qi Zhao, 2015: N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies, Virologica Sinica, 30, 449-456. doi: 10.1007/s12250-015-3664-6
[9]
Yingshuo Ma, Man Li, Lyu Xie, Na Gao, Dongying Fan, Kaihao Feng, Yao Yao, Yong Zhou, Ziyang Sheng, Hongning Zhou, Hui Chen, Jing An, 2021: Seroepidemiologic Study on Convalescent Sera from Dengue Fever Patients in Jinghong, Yunnan, Virologica Sinica.
[10]
Zhichao Yin, Yuanyuan Wu, Rui Zhu, Longfa Xu, Yu Lin, Hongwei Yang, Wenkun Fu, Qiongzi Huang, Dongqing Zhang, Jue Wang, Wei Wang, Yingbin Wang, Tong Cheng, Ningshao Xia, 2021: Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation, Virologica Sinica, 36, 1575-1584. doi: 10.1007/s12250-021-00444-1
[11]
Ting Tu, Jianbo Zhan, Danlei Mou, Wei Li, Bin Su, Tong Zhang, Tao Li, Ning Li, Hao Wu, Cong Jin, Huabiao Chen, 2017: In vitro inhibition of HIV-1 replication in autologous CD4⁺ T cells indicates viral containment by multifactorial mechanisms, Virologica Sinica, 32, 485-494. doi: 10.1007/s12250-017-3992-9
[12]
Peng-cheng Yu, Akira Noguchi, Satoshi Inoue, Qing Tang, Simon Rayner, Guo-dong Liang, 2012: Comparison of RFFIT Tests with Different Standard Sera and Testing Procedures^*, Virologica Sinica, 27, 187-193. doi: 10.1007/s12250-012-3247-8
[13]
Jiang-Fan Li, Lei He, Yong-Qiang Deng, Shu-Hui Qi, Yue-Hong Chen, Xiao-Lu Zhang, Shi-Xiong Hu, Rui-Wen Fan, Guang-Yu Zhao, Cheng-Feng Qin, 2021: Generation and Characterization of a Nanobody Against SARS-CoV, Virologica Sinica, 36, 1484-1491. doi: 10.1007/s12250-021-00436-1
[14]
Dan Luo, Yuanjiu Miao, Xianliang Ke, Zhongyuan Tan, Chun Hu, Penghui Li, Ting Wang, Yuan Zhang, Jianhong Sun, Yan Liu, Hanzhong Wang, Zhenhua Zheng, 2020: Baculovirus Surface Display of Zika Virus Envelope Protein Protects against Virus Challenge in Mouse Model, Virologica Sinica, 35, 637-650. doi: 10.1007/s12250-020-00238-x
[15]
Yuelin Wang, Wei Dou, Yingying Chen, Ke Liu, Mengjun Li, Tyuji Hoshino, Yushan Jiang, Vladislav Victorovich Khrustalev, Alexey V. Churov, Alexander N. Orekhov, Wei Zhao, Ling Li, Yang Yang, Chenguang Shen, 2026: Development and characterization of neutralizing monoclonal antibodies against clinically relevant human adenovirus subgroup B serotypes, Virologica Sinica, 41, 404-412. doi: 10.1016/j.virs.2026.03.017
[16]
Hao Chen, Rui Zhu, Yuanyuan Wu, Zhifeng Ke, Yubo Wu, Dongqing Zhang, Yuxiang Zou, Jiaying Wu, Xuejun Feng, Zhichao Yin, Mujin Fang, Ningshao Xia, Longfa Xu, Tong Cheng, 2025: A dual monoclonal antibody-based sandwich ELISA for detection of potent vaccine immunogen against Coxsackievirus B1, Virologica Sinica, 40, 1050-1053. doi: 10.1016/j.virs.2025.11.007
[17]
Yang Li, Lele Xu, Dian Jiao, Zifang Zheng, Zhihao Chen, Yang Jing, Zhiwei Li, Zhiqian Ma, Yingtong Feng, Xuyang Guo, Yumiao Wang, Yuan He, Haixue Zheng, Shuqi Xiao, 2023: Genomic similarity and antibody-dependent enhancement of immune serum potentially affect the protective efficacy of commercial MLV vaccines against NADC30-like PRRSV, Virologica Sinica, 38, 813-826. doi: 10.1016/j.virs.2023.08.010
[18]
Xingli Xu, Yufeng He, Shengtao Fan, Min Feng, Guorun Jiang, Lichun Wang, Ying Zhang, Yun Liao, Qihan Li, 2019: Reducing Viral Inhibition of Host Cellular Apoptosis Strengthens the Immunogenicity and Protective Efficacy of an Attenuated HSV-1 Strain, Virologica Sinica, 34, 673-687. doi: 10.1007/s12250-019-00156-7
[19]
Bihao Wu, Haiwei Zhang, Xiangxing He, Zhe Zhang, Xiaohui Liu, Rui Gong, 2026: A C-type single-domain antibody with protective efficacy against H1N1 via respiratory administration, Virologica Sinica, 41, 688-699. doi: 10.1016/j.virs.2026.05.007
[20]
Na Li, Zhiqiang Li, Yan Fu, Sheng Cao, 2020: Cryo-EM Studies of Virus-Antibody Immune Complexes, Virologica Sinica, 35, 1-13. doi: 10.1007/s12250-019-00190-5